Drug research

Timolol eye drops 0.5%

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Timolol maleate ophthalmic solution, 0.5%

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantNCT07075718	Glaukos Corporation	Phase 2	Recruiting	2028-03Estimated
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantNCT07495852	Glaukos Corporation	Phase 3	Recruiting	2028-06Estimated

Glaukos CorporationRecruitingPrimary completion: 2028-03 · Estimated

Trial details

Glaukos CorporationRecruitingPrimary completion: 2028-06 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.